Search
for
Sort by
Research 901–930 of 1000+
- Endoscopic Browplasty
- Novel <i>ABCD1</i> Gene Mutation in Adrenomyeloneuropathy with Hypoplasia and Agenesis of the Corpus Callosum
- Hair Transplant
- Ethnic Considerations in Hair Restoration Surgery
- Megasessions
- Promotion of mouse ameloblast proliferation by Lgr5 mediated integrin signaling
- Cosmetic Surgery in the United States: Its Past and Present
- The O'Connor Tweezer Dexterity Test as a Screening Tool for Hiring Surgical Hair Restoration Assistants
- Hair Transplantation in Females
- The overexpression of R-spondin 3 affects hair morphogenesis and hair development along with the formation and maturation of the hair follicle stem cells
- Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-based Treatment
- Hair Transplant for Eyebrow Restoration
- Head and Neck Reconstruction
- Hyperadrenocorticism in Ferrets
- Advances in aesthetic hair restoration
- Chest Hair Used as Donor Material in Hair Restoration Surgery
- A Single-Scar Technique for Donor Harvesting in Hair Transplantation Surgery
- Advanced Use of Tissue Adhesive in Hair Transplantation
- Variation in platelet‐rich plasma compositions used for wound healing indications
- Variability of Retail Pricing of Generic Urologic Medications in a Major US Metropolitan Area
- Acne in Dark Skin
- Endocrine evaluation of hirsutism
- Limits of Visual Detection for Finasteride Polymorphs in Prepared Binary Mixtures: Analysis by X‐ray Powder Diffraction
- Pitfalls of Midface Surgery
- Relative binding affinity of novel steroids to androgen receptors in hamster prostate
- THE WATER SOLUBLE VITAMINS
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- PCOS and Obesity: Contraception Challenges
- Restoring neuropetide Y levels in the hypothalamus ameliorates premature aging phenotype in mice
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial